Search

Your search keyword '"Lukas Käsmann"' showing total 4 results
Start Over Author "Lukas Käsmann" Publisher wiley
4 results on '"Lukas Käsmann"'

3. Pooled analysis on image‐guided moderately hypofractionated thoracic irradiation in inoperable node‐positive/recurrent patients with non–small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve

Author

Chukwuka Eze, Julian Elias Guggenberger, Nina‐Sophie Schmidt‐Hegemann, Saskia Kenndoff, Julian Taugner, Lukas Käsmann, Stephan Schönecker, Benedikt Flörsch, Minglun Li, Claus Belka, and Farkhad Manapov

Subjects
Aged, 80 and over, Cancer Research, Lung Neoplasms, Oncology, Carcinoma, Non-Small-Cell Lung, Humans, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Lung, Aged
Abstract

The objective of this study was to investigate the feasibility and efficacy of image-guided moderately hypofractionated thoracic radiotherapy (hypo-IGRT) in patients with non-small cell lung cancer (NSCLC) with poor performance status and severely limited pulmonary function and reserve.Consecutive inoperable patients who had node-positive, stage IIB-IIIC (TNM, 8th edition) or recurrent NSCLC, had an Eastern Cooperative Oncology Group performance status ≥1, and had a forced expiratory volume in 1 second (FEVBetween 2014 and 2021, 47 consecutive patients with a median age of 72 years (range, 52.2-88 years) were treated. At baseline, the median FEVPatients with inoperable node-positive NSCLC, a poor performance status, and severely limited lung function can be safely and effectively treated with individualized moderately hypofractionated IGRT. The achieved survival rates for this highly multimorbid group of patients were encouraging.

Published
2022

4. Combination of pembrolizumab with radiotherapy can change treatment paradigm in metastatic 'non‐driver' non‐small‐cell lung cancer: Assembling a path

Author

Julian Taugner, Lukas Käsmann, Benedikt Flörsch, Chukwuka Eze, and Farkhad Manapov

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, business.industry, medicine.medical_treatment, Pembrolizumab, Antibodies, Monoclonal, Humanized, medicine.disease, Radiation therapy, Antineoplastic Agents, Immunological, Carcinoma, Non-Small-Cell Lung, Internal medicine, Path (graph theory), medicine, Humans, Immunology and Allergy, Non small cell, business, Lung cancer, Genetics (clinical)
Published
2021

Catalog

Books, media, physical & digital resources
See catalog results